RADIN Health and AZmed have expanded their strategic partnership following AZmed’s third US FDA clearance for AZtrauma, part of the Rayvolve AI Suite.
The expanded clearance broadens AZtrauma’s use beyond fracture detection to include joint effusions and dislocations on X-rays across adult and paediatric populations aged two years and above. The development addresses a key operational challenge in radiology, where rising imaging volumes and workforce constraints continue to place pressure on reporting workflows and turnaround times.
AZtrauma is positioned as an AI tool that supports radiologists by identifying and triaging musculoskeletal abnormalities before image review. Its expanded scope now covers three pathology categories on X-rays: fractures, joint effusions and dislocations. This may support more consistent prioritisation of urgent cases, particularly in emergency, trauma and paediatric imaging settings.
The clearance follows the publication of a 2026 Cohen et al. study validating the complete X-ray AI suite across 258,373 X-rays from 100 clinical centres in 26 countries and five continents. Such validation is relevant for radiology AI adoption, where clinical performance, workflow integration and generalisability across care settings remain important considerations.
Through the partnership, AZmed’s Rayvolve AI Suite modules, including AZtrauma and AZchest, are integrated into RADIN’s cloud-based platform. RADIN provides an all-in-one RIS, PACS, Dictation AI and Study Orchestration system, allowing AZmed’s structured reporting images and data to feed directly into RADIN PACS. This integration is intended to reduce manual transfer errors and support AI-driven reporting insights within existing radiology workflows.
RADIN’s platform also incorporates automated document processing for DICOM structured reports and AI OCR for handwritten notes, prescriptions and reports. Its AI-assisted dictation mode is reported to improve reporting speed by up to 70 percent compared with legacy dictation systems, supporting faster report creation and workflow throughput.
The target users include hospitals, imaging centres, radiology practices and teleradiology providers managing high X-ray volumes. The partnership reflects a broader shift in medical imaging AI from standalone detection tools toward embedded workflow infrastructure. As radiology departments face increasing demand, platforms that combine regulatory-cleared image analysis with reporting automation and orchestration tools may become more relevant to scalable diagnostic service delivery.
